SimonMed Imaging is integrating Infervision’s AI-powered InferRead Lung CT.AI technology into its facilities.
The move aims to improve the identification of pulmonary nodules and to provide 3D characterization and comparison of nodules. It will be integrated into CT chest scan readings, including those for lung cancer screening.
The technology automatically displays boxes around nodules in a new series providing standardized reporting of all nodule characteristics including image number, type of nodule, and volume. It also assesses previous exams to track changes in diameter and volume. In cases where pneumonia is suspected, the technology prioritizes them for immediate reporting.
The collaboration is one of multiple SimonMed Imaging AI projects underway for improved patient care, the company said.
